GlaxoSmithKline PLC (GSK.LN), the pharmaceutical and healthcare company, said Tuesday it has completed the extension of its strategic relationship with Aspen Pharmacare Holdings Ltd. and the acquisition of a 19% shareholding in the South African based pharmaceuticals company.


-On completion, Aspen issued 68.5 million ordinary shares to GSK in consideration for the transfer of assets.

-Taken together with Aspen shares acquired by GSK between signing and closing, this issue takes GSK's holding in Aspen to a total of 81.7 million shares.

-By London Bureau, Dow Jones Newswires; Contact Ian Walker; +44 (0)20 7842 9296;